Caron Jacobson, MD

home / authors / caron-jacobson,-md

Articles

Axi-Cel Demonstrates Efficacy in Non-Hodgkin Lymphoma, Including DLBCL

Axi-Cel Demonstrates Efficacy in Non-Hodgkin Lymphoma, Including DLBCL

December 22nd 2020

Caron Jacobson, MD, discusses the survival and response data for axicabtagene ciloleucel from the phase 1/2 ZUMA-1 trial.

Toxicity Profile of CAR T-Cell Therapy Appears Safe in Follicular and Marginal Zone Lymphomas

Toxicity Profile of CAR T-Cell Therapy Appears Safe in Follicular and Marginal Zone Lymphomas

July 6th 2020

Caron Jacobson, MD, discusses the safety findings from the phase 2 ZUMA-5 tidal evaluating axicabtagene ciloleucel in patients with follicular lymphoma and marginal zone lymphoma.